Treatment
|
Vehicle
|
RacL11
|
LPS
|
---|
FVIIa
|
0
|
1.97 ± 0.27*
|
2.89 ± 0.37*
|
No FVIIa
|
0
|
0
|
0
|
- Procoagulant activity (mean ± SD FXa generation in nM) was measured with and without exogenous FVIIa in monocyte-enriched PBMC fractions 4 h after infection with RacL11 (MOI of 1) or treatment with LPS (10 ng/mL) or vehicle (PBS) (n = 3).
- * p < 0.05 versus no FVIIa.